Fibrocell Science, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (28)

Latest Posts

About This Stock More About This Stock
Rayno Small Cap Biopharmaceutical Portfolio 2015 In Rally Mode - XBI Up 2.5%
Article By: Rod Raynovich
Tuesday, December 29, 2015 9:44 PM EDT
We recommended three new small caps at the October Bioinvestor Forum: Curis, Geron and Ocera Therapeutics. This forum offers the best window on emerging small companies in the fall, a good time to get a head start on biotech small cap investing.
In this article: ARRY, CRIS, GERN, XBI, IMMY, GLYC, FCSC, RXDX, OCRX
Read
2015 Life Science Sector Review As Biopharma Rally Fades
Article By: Rod Raynovich
Monday, December 28, 2015 8:00 PM EDT
This is not a good week for trading. Portfolio managers are re-jiggering positions so you may not see the trends correctly. Many biotech stocks started rallying off the bottom in October then again around December 11.
In this article: CRIS, GERN, REGN, SGEN, ALKS, BIIB, CLVS, PCYC, XBI, XLV, ABBV, CMRX, FCSC, RXDX
Read
Rayno Small Caps Outperform: New Long Idea - Imprimis Pharmaceuticals
Article By: Rod Raynovich
Tuesday, December 1, 2015 7:00 PM EDT
Today we added a new small cap speculative pick, Imprimis Pharmaceutical, an emerging pharmaceutical Company focused on developing and commercializing proprietary compounded, customized drug therapies to physicians and patients in the US.
In this article: ARRY, CRIS, GERN, IMMY, GLYC, FCSC, RXDX
Read
Biotech Rally Underway Trying To Overcome Gloomy Data
Article By: Rod Raynovich
Saturday, November 14, 2015 11:14 AM EDT
As of mid-morning trading the biotech and drug sector is one of the few winners yesterday. Energy has been the major drag on the market (crude down again yesterday) but materials are trying to bounce back yesterday with the XLB up over 1%.
In this article: ALR, VRX, ALNY, CRIS, ILMN, INCY, ISIS, SGEN, AMGN, CELG, CLVS, GILD, PACB, QGEN, VRTX, XLB, FCSC, NSTG, RXDX
Read
Biotech Bear Market: After The Bubble Burst…
Article By: Rod Raynovich
Tuesday, October 13, 2015 1:44 PM EDT
Biotech stocks are “bobbing” just above the early October bottom with a bit of buying support but still 13% off mid-September highs. Sentiment remains negative because of long term pricing concerns.
In this article: IBB, XLV, FCSC Also: ALXN, SGEN, BIIB, CELG, CLVS, GILD, VRTX, ABBV
Read

Latest Tweets for $FCSC

No tweets yet!

PARTNER HEADLINES